Latest News On Louisiana

Latest 蘑菇影院 Health News Stories

Psychoactive Drugs Are Having a Moment. The FDA Will Soon Weigh In.

蘑菇影院 Health News Original

Mounting evidence suggests psychoactive drugs including LSD, ketamine, mushrooms, and MDMA can be powerful treatments for severe depression and PTSD. But not everyone is convinced. And even if such drugs gain FDA approval, safety protocols could render them extremely expensive.

蘑菇影院 Health News' 'What the Health?': Anti-Abortion Hard-Liners Speak Up

Podcast

While Republican candidates in many states downplay their opposition to abortion, the most vehement wing of the movement, which helped overturn Roe v. Wade 鈥 those who advocate prosecuting patients, outlawing contraception, and banning IVF 鈥 are increasingly outspoken. Meanwhile, some state legislatures continue to advance new restrictions, like a proposal moving in Louisiana to include abortion medications mifepristone and misoprostol on the list of the most dangerous drugs. Alice Miranda Ollstein of Politico, Rachel Roubein of The Washington Post, and Joanne Kenen of the Johns Hopkins schools of public health and nursing and Politico Magazine join 蘑菇影院 Health News鈥 Julie Rovner to discuss these stories and more. Also this week, Rovner interviews Shefali Luthra of The 19th about her new book on abortion in post-Roe America, 鈥淯ndue Burden.鈥

A New Orleans Neighborhood Confronts the Racist Legacy of a Toxic Stretch of Highway

蘑菇影院 Health News Original

New federal funds aim to address an array of problems created by highway construction in minority neighborhoods. These are economic, social, and, perhaps above all, public health problems. In New Orleans鈥 Treme neighborhood, competing plans for how to deal with harm done by the Claiborne Expressway reveal the challenge of how to mitigate them meaningfully.

States Target Health Insurers鈥 鈥楶rior Authorization鈥 Red Tape

蘑菇影院 Health News Original

Doctors, patients, and hospitals have railed for years about the prior authorization processes that health insurers use to decide whether they鈥檒l pay for patients鈥 drugs or medical procedures. The Biden administration announced a crackdown in January, but some state lawmakers are looking to go further.